In patients with type 2 diabetes the presence of Hashimoto's thyroiditis reduces the beneficial effect of dipeptidyl peptidase-4 inhibitor on plasma glucose control.
第一作者:
Takuya,Watanabe
第一单位:
Department of Endocrinology and Metabolism, Saku Central Hospital Advanced Care Center, Nagano 385-0051, Japan.
作者:
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);血糖(Blood Glucose);糖尿病, 2型(Diabetes Mellitus, Type 2);二肽基肽酶Ⅳ抑制剂(Dipeptidyl-Peptidase IV Inhibitors);女(雌)性(Female);桥本病(Hashimoto Disease);人类(Humans);降血糖药(Hypoglycemic Agents);男(雄)性(Male);中年人(Middle Aged);治疗结果(Treatment Outcome)
DOI
10.1507/endocrj.EJ20-0620
PMID
33408313
发布时间
2021-11-30
- 浏览0

Endocrine journal
599-603页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文